Your browser doesn't support javascript.
loading
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.
Sajadi, Mohammad Mohseni; Dashti, Amir; Rikhtegaran Tehrani, Zahra; Tolbert, William D; Seaman, Michael S; Ouyang, Xin; Gohain, Neelakshi; Pazgier, Marzena; Kim, Dongkyoon; Cavet, Guy; Yared, Jean; Redfield, Robert R; Lewis, George K; DeVico, Anthony L.
Afiliación
  • Sajadi MM; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Medicine, Baltimore VA Medical Center, Baltimore, MD 21201, USA; Department of Medicine, University of Maryland School of Medi
  • Dashti A; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Rikhtegaran Tehrani Z; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Virology Department, Pasteur Institute of Iran, Tehran, Iran.
  • Tolbert WD; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Ouyang X; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Gohain N; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Pazgier M; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Kim D; Atreca, Inc., Redwood City, CA 94063, USA.
  • Cavet G; Atreca, Inc., Redwood City, CA 94063, USA.
  • Yared J; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Redfield RR; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Lewis GK; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • DeVico AL; Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Cell ; 173(7): 1783-1795.e14, 2018 06 14.
Article en En | MEDLINE | ID: mdl-29731169
ABSTRACT
Anti-HIV-1 envelope broadly neutralizing monoclonal antibodies (bNAbs) isolated from memory B cells may not fully represent HIV-1-neutralizing profiles measured in plasma. Accordingly, we characterized near-pan-neutralizing antibodies extracted directly from the plasma of two "elite neutralizers." Circulating anti-gp120 polyclonal antibodies were deconvoluted using proteomics to guide lineage analysis of bone marrow plasma cells. In both subjects, a single lineage of anti-CD4-binding site (CD4bs) antibodies explained the plasma-neutralizing activity. Importantly, members of these lineages potently neutralized 89%-100% of a multi-tier 117 pseudovirus panel, closely matching the specificity and breadth of the circulating antibodies. X-ray crystallographic analysis of one monoclonal, N49P7, suggested a unique ability to bypass the CD4bs Phe43 cavity, while reaching deep into highly conserved residues of Layer 3 of the gp120 inner domain, likely explaining its extreme potency and breadth. Further direct analyses of plasma anti-HIV-1 bNAbs should provide new insights for developing antibody-based antiviral agents and vaccines.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína gp120 de Envoltorio del VIH / VIH-1 / Anticuerpos Neutralizantes Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína gp120 de Envoltorio del VIH / VIH-1 / Anticuerpos Neutralizantes Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article